New EULAR guidelines speed RA treatment switches as rheumatoid arthritis biosimilars and biosimilar cost savings push earlier ...

Early diagnosis leads to earlier treatment. With earlier treatment of rheumatoid arthritis (RA), there is a better chance for less radiographic damage, less disability and thus lower overall costs of ...

1 in 100 people in Britain today live with rheumatoid arthritis (RA). Unlike osteoarthritis (OA), RA is caused not by wear and tear but by the body's immune system attacking its own joints. RA can ...

Morning stiffness is common for people with arthritis and that got researchers to thinking that if they could time drug therapy to match the body’s rhythms when pain receptors are most active, they ...

Rheumatoid arthritis-associated interstitial lung disease (ILD) presents a paradox: it is common and a major cause of ...

Dr. Cush is the Director of Clinical Rheumatology at Baylor Scott & White Research Institute and Professor of Medicine and Rheumatology at Baylor University Medical Center, Dallas, TX. He received his ...

First published in 2010, the EULAR recommendations for the management of RA, the most frequent inflammatory rheumatic disease, have been relied upon by healthcare professionals and organizations ...